PNW
66
3
NRG
49
-3
NI
75
2
SRE
63
-3
EQT
59
2
ZTS
47
2
BBY
40
3
HUM
48
6
SYF
85
2
INTU
51
2
AES
39
-4
IFF
53
2
RRC
63
3
WAT
47
5
XOM
47
5
ED
48
3
LLY
39
9
EQR
54
-2
VLO
40
-2
DAL
80
-4
PNW
66
3
NRG
49
-3
NI
75
2
SRE
63
-3
EQT
59
2
ZTS
47
2
BBY
40
3
HUM
48
6
SYF
85
2
INTU
51
2
AES
39
-4
IFF
53
2
RRC
63
3
WAT
47
5
XOM
47
5
ED
48
3
LLY
39
9
EQR
54
-2
VLO
40
-2
DAL
80
-4
Financhill
Back

Theriva Biologics 10K Form

Sell
42

TOVX
Theriva Biologics

Last Price:
1.24
Seasonality Move:
98.81%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TOVX News And Ratings

See the #1 stock for the next 7 days that we like better than TOVX

TOVX Financial Statistics

Sales & Book Value

Annual Sales: $2.61M
Cash Flow: $-3.91M
Price / Cash Flow: 0
Annual Sales: $9.41
Price / Book: 0.14

Profitability

EPS (TTM): -33.18000
Net Income (TTM): $-26.69M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Theriva Biologics Earnings Forecast

Key Theriva Biologics Financial Ratios

  • The Selling, General & Administrative Expenses for TOVX have been equal to 80.99% of Gross Profit Margin.
  • The Interest Expense is -0.26% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 12 years.

Theriva Biologics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: TOVX
Website: therivabio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TOVX Technical Analysis vs Fundamental Analysis

Sell
42
Theriva Biologics (TOVX) is a Sell

Is Theriva Biologics a Buy or a Sell?

  • Theriva Biologics stock is rated a Sell
    The current Theriva Biologics [TOVX] share price is $1.26. The Score for TOVX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.